| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/24/2023 | 516.44% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 08/16/2023 | 756.16% | HC Wainwright & Co. | → $25 | Reiterates | Buy → Buy |
| 08/15/2023 | 447.95% | BTIG | $20 → $16 | Maintains | Buy |
| 08/15/2023 | 756.16% | HC Wainwright & Co. | → $25 | Reiterates | Buy → Buy |
| 06/16/2023 | 584.93% | BTIG | $4 → $20 | Maintains | Buy |
| 06/16/2023 | 756.16% | HC Wainwright & Co. | → $25 | Reiterates | Buy → Buy |
| 05/15/2023 | 139.73% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 03/30/2023 | 139.73% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 11/16/2022 | 36.99% | BTIG | $8 → $4 | Maintains | Buy |
| 01/24/2022 | 105.48% | B. Riley Securities | $13 → $6 | Maintains | Buy |
| 05/18/2021 | 276.71% | BTIG | → $11 | Initiates Coverage On | → Buy |
| 12/23/2020 | 345.21% | B. Riley FBR | → $13 | Reinstates | → Buy |
| 10/02/2020 | 208.22% | B. Riley Securities | → $9 | Initiates Coverage On | → Buy |
| 05/12/2020 | 345.21% | Oppenheimer | $15 → $13 | Maintains | Outperform |
| 11/20/2019 | 139.73% | Cantor Fitzgerald | → $7 | Assumes | → Overweight |
| 08/13/2019 | — | HC Wainwright & Co. | Initiates Coverage On | → Buy | |
| 08/13/2019 | 139.73% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 06/21/2019 | 139.73% | Cantor Fitzgerald | → $7 | Initiates Coverage On | → Overweight |
What is the target price for Mustang Bio (MBIO)?
The latest price target for Mustang Bio (NASDAQ: MBIO) was reported by Cantor Fitzgerald on August 24, 2023. The analyst firm set a price target for $18.00 expecting MBIO to rise to within 12 months (a possible 516.44% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mustang Bio (MBIO)?
The latest analyst rating for Mustang Bio (NASDAQ: MBIO) was provided by Cantor Fitzgerald, and Mustang Bio reiterated their overweight rating.
When is the next analyst rating going to be posted or updated for Mustang Bio (MBIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mustang Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mustang Bio was filed on August 24, 2023 so you should expect the next rating to be made available sometime around August 24, 2024.
Is the Analyst Rating Mustang Bio (MBIO) correct?
While ratings are subjective and will change, the latest Mustang Bio (MBIO) rating was a reiterated with a price target of $0.00 to $18.00. The current price Mustang Bio (MBIO) is trading at is $2.92, which is within the analyst's predicted range.